Raymond James Reiterates “Strong-Buy” Rating for Encompass Health (NYSE:EHC)

Raymond James reissued their strong-buy rating on shares of Encompass Health (NYSE:EHC) in a research note released on Friday, Benzinga reports. Raymond James currently has a $95.00 price target on the stock, up from their prior price target of $85.00.

Several other research analysts have also recently issued reports on EHC. Stephens reaffirmed an overweight rating and issued a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. William Blair reaffirmed an outperform rating on shares of Encompass Health in a research report on Wednesday, February 7th. Royal Bank of Canada reiterated an outperform rating and issued a $83.00 price target on shares of Encompass Health in a research report on Friday, February 9th. Barclays boosted their price objective on Encompass Health from $101.00 to $108.00 and gave the stock an overweight rating in a report on Thursday. Finally, Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a buy rating in a report on Friday, February 9th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Encompass Health has a consensus rating of Buy and an average target price of $88.13.

Encompass Health Trading Down 0.3 %

Shares of EHC stock opened at $82.47 on Friday. The stock has a 50-day simple moving average of $78.25 and a 200 day simple moving average of $70.96. The stock has a market capitalization of $8.26 billion, a P/E ratio of 22.29, a P/E/G ratio of 1.50 and a beta of 0.94. Encompass Health has a fifty-two week low of $57.55 and a fifty-two week high of $85.84. The company has a quick ratio of 1.28, a current ratio of 1.37 and a debt-to-equity ratio of 1.14.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The company had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm posted $0.88 EPS. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. On average, sell-side analysts expect that Encompass Health will post 4.1 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.15 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.60 annualized dividend and a yield of 0.73%. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

Institutional Trading of Encompass Health

A number of hedge funds have recently made changes to their positions in the stock. Legacy Wealth Asset Management LLC grew its position in Encompass Health by 1.5% during the first quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock valued at $712,000 after purchasing an additional 130 shares in the last quarter. Benjamin Edwards Inc. grew its holdings in shares of Encompass Health by 3.8% during the 4th quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock valued at $259,000 after acquiring an additional 142 shares in the last quarter. Horrell Capital Management Inc. increased its stake in shares of Encompass Health by 0.5% in the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after acquiring an additional 147 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Encompass Health by 31.9% during the first quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock worth $51,000 after acquiring an additional 149 shares in the last quarter. Finally, Treasurer of the State of North Carolina boosted its position in Encompass Health by 0.5% during the third quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock valued at $3,246,000 after purchasing an additional 231 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.